Member Exclusive

Cell and Gene Therapy Catapult manufacturing center receives new investment

A £12 million award from the UK Government’s Industrial Strategy Challenge Fund will double the capacity of the Cell and Gene Therapy Catapult manufacturing center in Stevenage, UK.

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.

Register

1 Comments

Go to the profile of James L. Sherley, M.D., Ph.D.

Given these exciting resource developments, we at Asymmetrex hope that Catapult stem cell therapy process engineers with visit http://asymmetrex.com/our-serv... and get us involved as essential partners in their future endeavors to accelerate development of new stem cell-based therapies that use natural tissue stem cells.  We have the best tools for manufacturing tissue stem cells specifically, instead of the more abundant non-stem committed cells that always accompany them.

James L. Sherley, M.D., Ph.D.

Founder and Director, Asymmetrex